Abstract
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the cellular disease dynamics remains limited. In our unique COVID-19 human challenge study we used single cell genomics of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in 16 seronegative individuals challenged with preAlpha-SARS-CoV-2. Our analyses revealed rapid changes in cell type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific timepoints or infection status. We observed that the interferon response in blood precedes the nasopharynx, and that nasopharyngeal immune infiltration occurred early in transient but later in sustained infection, and thus correlated with preventing sustained infection. Ciliated cells showed an acute response phase, upregulated MHC class II while infected, and were most permissive for viral replication, whilst nasal T cells and macrophages were infected non-productively. We resolve 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our novel computational pipeline (Cell2TCR) identifies activated antigen-responding clonotype groups and motifs in any dataset. Together, we show that our detailed time series data can serve as a “Rosetta stone” for the epithelial and immune cell responses, and reveals early dynamic responses associated with protection from infection.
The "Black Box" of Early Infection
Most clinical data on COVID-19 is derived from symptomatic patients, leaving the critical first days of infection—the period where the immune system either clears the virus or allows it to take hold—largely unobserved. Natural infection studies struggle to capture these moments because the exact time of exposure is rarely known, and individuals who successfully "abort" an infection before testing positive are missed entirely.
This study utilizes a controlled human challenge model to resolve these early dynamics. By tracking 16 healthy, seronegative young adults from the moment of intranasal inoculation with a low dose of pre-Alpha SARS-CoV-2, researchers were able to map the immediate local response in the nose versus the systemic response in the blood.
Methods and High-Resolution Mapping
The study employed a massive single-cell multi-omics approach, collecting longitudinal samples of nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs) at seven timepoints from Day -1 to Day 28.
The resulting dataset comprises over 600,000 single-cell transcriptomes. Techniques included scRNA-seq for transcriptomics, CITE-seq for surface protein quantification (123 markers), and single-cell TCR/BCR-seq to track immune repertoires. To analyze this data, the team developed Cell2TCR, a computational pipeline that identifies antigen-specific T cell clonotypes by linking their transcriptomic "activated" state to their TCR sequences.
Key Insights: Timing is Everything
Systemic "Early Warning"
A major finding was that the interferon (IFN) response—the body's primary antiviral alarm—peaks in the blood (Day 3) before it becomes widespread in the nose (Day 5). This suggests the immune system broadcasts the infection systemically before local tissues are fully engaged.
Speed of Infiltration
The study categorized participants into three groups: sustained, transient, and abortive infections. In transient infections, where the virus is cleared quickly, immune cells flooded the nose by Day 1. In sustained infections, this infiltration was delayed until Day 5. This suggests that the speed of local immune recruitment is a deciding factor in preventing a productive infection.
Viral Factories and Cellular Communication
While many cells become infected, a tiny subset (4%) of "hyper-infected" ciliated cells produced 67% of all detectable viral RNA. These cells switched to an anti-inflammatory state, likely to maximize viral production while evading detection. Interestingly, infected ciliated cells also upregulated MHC class II, a molecule typically reserved for professional immune cells, suggesting they may directly communicate with CD4+ T cells to coordinate their own destruction.
Results and Implications
The study resolved 202 distinct cell states, including 54 T cell states. Activated T and B cells peaked at Day 10, coinciding with viral clearance. Using Cell2TCR, the authors identified 254 COVID-associated T cell clonotype groups, many sharing "public" motifs across different individuals, indicating a highly convergent human response to specific viral peptides.
Furthermore, the data revealed that while nasal T cells and macrophages can contain viral RNA, they do not support viral replication, acting as viral "sinks" rather than spreaders.
Limitations
While groundbreaking, the study's cohort of 16 young, healthy, seronegative participants may not reflect the dynamics in elderly populations or those with pre-existing immunity. Additionally, the use of a pre-Alpha strain means that newer variants like Omicron, which have different entry kinetics, may exhibit different cellular dynamics. However, the Cell2TCR pipeline and the public reference atlas at covid19cellatlas.org provide a powerful framework for future research into infectious diseases, cancer, and autoimmunity.
Summary updated